Docstoc

Endo Partnering 2005-2012

Document Sample
Endo Partnering 2005-2012 Powered By Docstoc
					qwertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfgh
jklzxcvbnmqwertyuiopasdfghjklzxcvb
nmqwertyuiopasdfghjklzxcvbnmqwer
tyuiopasdfghjklzxcvbnmqwertyuiopas
dfghjklzxcvbnmqwertyuiopasdfghjklzx
           Endo Partnering 2005-2012

cvbnmqwertyuiopasdfghjklzxcvbnmq
                      To Know More...

wertyuiopasdfghjklzxcvbnmqwertyuio
pasdfghjklzxcvbnmqwertyuiopasdfghj
klzxcvbnmqwertyuiopasdfghjklzxcvbn
mqwertyuiopasdfghjklzxcvbnmqwerty
uiopasdfghjklzxcvbnmqwertyuiopasdf
ghjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmrty
uiopasdfghjklzxcvbnmqwertyuiopasdf
ghjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmqw
ertyuiopasdfghjklzxcvbnmqwertyuiop
Endo Partnering 2005-2012

 Bharat Book introduces a report " Endo Partnering 2005-2012 " This report provides all the
information you require to better understand Eli Lilly and its partnering interests and activities over the
past five years.

 The Partnering Agreements with Endo report provides an in-depth insight into the partnering interests
and activites of one of the worlds leading biopharma companies.
 This report provides all the information you require to better understand Eli Lilly and its partnering
interests and activities over the past five years.
 On demand company reports are prepared upon purchase to ensure inclusion of the most up to date
deal and company data.
 The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-
Rom version purchased, the report will be sent by courier using express service.
 http://www.bharatbook.com/healthcare-market-research-reports/endo-partnering-2005-2012.html

 Description
 This report provides all the information you require to better understand Endo and its partnering
interests and activities over the past seven years.

 One of the key aspects of partnering is finding those companies that are potential partners for the
development and commercialization of the next generation of therapies as developed by innovative
biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests
and making contact to initiate discussions.

 Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver
the company’s business development objectives.

 The initial chapters of this report provide an orientation of bigpharma’s dealmaking and business
activities. Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top 50 leading
biopharma companies based on 2010 pharmaceutical revenues and their respective partnering activity.
Chapter 3 provides an overview of the leading partnering and M&A 2005 to present date based on
headline value.

 Chapter 4 provides details on how to approach bigpharma companies with partnering opportunities
whilst chapter 5 lists forthcoming partnering events and conferences where bigpharma companies will
be present to discuss opportunities face to face.

 The main body of the report is provided in chapter 6. A profile of the company provides everything
required to assess the suitability of a company as a prospective partner. This includes a company
overview, partnering interests, partnering activity according to deal type, industry sector, phase of
development, and therapy area. The profile also includes in-depth contact information for individuals
within the business development function.
 The deals are listed by deal type, stage of development and therapy focus, allowing easy access to
deals and alliances of interest. Every deal record links to an online, live version of the deal record at the
Current Agreements deals and alliances database. Where available, deal records also include the
contract document as disclosed at the SEC.

 One of the key aspects of partnering is conducting due diligence on a partner to determine under what
terms a prospective partner agrees to a partnering relationship.

 Understanding the flexibility of prospective partners’ negiotated deals terms provides critical insight
into the negotiation process in termsof what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the
detail in terms of how payments are triggered – contract documents provide this insight where press
releases and databases do not.

 In addition, contract documents provide the answers to numerous questions about a prospective
partner’s flexibility on a wide range of important issues, many of which will have a significant impact
on each parties ability to derive value from the deal.

For more information kindly visit :
Endo Partnering 2005-2012

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/#!/Sandhya3B
Our Blogs: http://in.linkedin.com/in/bharatbook
http://healthcareraj.blogspot.com/
Follow:

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:6
posted:7/14/2012
language:
pages:3
Description: Bharat Book introduces a report " Endo Partnering 2005-2012 " This report provides all the information you require to better understand Eli Lilly and its partnering interests and activities over the past five years.